Industry Primer — Healthcare
Ambulatory surgery centers (ASCs) perform same-day surgical, diagnostic, and preventive procedures outside of hospital settings. The U.S. has over 6,100 Medicare-certified ASCs generating roughly $50 billion in annual revenue. The sector has been a structural winner from the site-of-service migration trend as payers, employers, and patients seek lower-cost alternatives to hospital outpatient departments (HOPDs), where the same procedure can cost 2-3x more. ASCs operate with significantly lower overhead, no emergency department obligations, and specialized clinical focus that drives superior throughput and outcomes. Ownership ranges from physician-owned single-specialty centers to large platforms like USPI (Tenet), SCA Health (UnitedHealth/Optum), and Surgery Partners.
Near-term growth is accelerating. CMS continues to expand the list of procedures approved for ASC settings, adding total joint replacements, cardiac catheterizations, and complex spine cases. Commercial payer steering toward ASCs is intensifying as employers demand cost transparency. Surgical volumes are robust across orthopedics, ophthalmology, gastroenterology, and pain management. The primary challenge is physician recruitment and alignment — ASCs depend on surgeon case volume, and employment models (vs. ownership stakes) are shifting the economic relationship. Anesthesia shortages are creating scheduling bottlenecks in certain geographies.
The five-year trajectory is highly favorable. The ASC addressable market is expanding as technology enables more complex procedures in outpatient settings — robotic-assisted surgery, advanced imaging, and improved anesthesia protocols are all enablers. Private equity interest remains intense, with platforms pursuing roll-up strategies to build regional density and payer negotiating leverage. Expect continued consolidation of physician-owned centers into larger platforms. Revenue growth of 8-12% annually is achievable through a combination of same-facility volume growth, new center development, and case complexity migration. Margin expansion opportunities exist through supply chain group purchasing, revenue cycle optimization, and labor efficiency.
Over the next decade, ASCs will capture an increasing share of total surgical volume, potentially reaching 60-70% of all outpatient procedures (up from ~50% today). The aging baby boomer population will drive significant demand for joint replacements, cataract surgery, cardiac procedures, and cancer-related interventions. Micro-hospital and hybrid models blending ASC efficiency with limited inpatient capability will emerge. The primary long-term risk is reimbursement compression — as ASC volumes grow, CMS and commercial payers may reduce ASC rates, narrowing the HOPD-to-ASC differential that drives the value proposition.
Surgeon recruitment and retention drives case volume and revenue. Payer mix, particularly the commercial-to-Medicare ratio, determines profitability per case. CMS reimbursement policy, specifically the ASC-approved procedure list and rate updates, defines the addressable market. Real estate and build-out costs influence new center economics (typically $3-8M per center). State licensing and certificate-of-need requirements vary significantly and impact market entry. Supply chain costs run 15-25% of revenue, and group purchasing leverage is a key scale advantage.
AI is a meaningful enabler for ASC operations. Scheduling optimization algorithms can improve OR utilization from typical 60-65% to 80%+, directly boosting revenue per center. Predictive analytics for patient risk stratification help identify candidates safe for outpatient procedures vs. those requiring hospital settings, expanding the eligible patient pool. Computer-assisted surgical planning and intraoperative guidance improve outcomes and reduce complications. Automated prior authorization and eligibility verification reduce administrative burden and accelerate revenue collection. AI-powered inventory management for surgical supplies and implants can reduce waste and carrying costs.
ASCs can implement operating room scheduling optimization tools that increase case volumes by reducing turnover time and minimizing gaps — even a 10-15% improvement in room utilization drives meaningful revenue uplift. Automated pre-authorization and benefits verification reduces case cancellations and accelerates collections. Clinical documentation automation improves coding accuracy for higher-acuity cases. Supply chain management platforms standardize implant and consumable purchasing across multi-site portfolios, leveraging volume for 15-25% savings on surgical supplies.
Surgery Partners (SGRY) operates ~180 facilities across 31 states with a multi-specialty model. USPI, owned by Tenet Healthcare (THC), is the largest ASC platform with 480+ centers. SCA Health, acquired by UnitedHealth/Optum, operates 320+ centers with deep payer integration. U.S. Physical Therapy (USPH) operates physical therapy clinics with an adjacent ambulatory model. Ensign Group (ENSG) primarily operates in post-acute but has expanding outpatient capabilities.